Abstract
Cherry hemangiomas are common vascular proliferative lesions that can be concerning from a cosmetic perspective. Laser therapy is often used to eradicate cherry hemangiomas, but some lesions require multiple treatments or do not resolve at all. The suboptimal response to laser treatment may be due to limitations in penetration depth by vascular lasers such as the pulsed dye laser. Optical coherence tomography is a low-energy, light-based imaging device that can evaluate the depth and extent of vascular lesions such as cherry hemangiomas by allowing visualization of tissue structure and blood vessel architecture, which cannot be appreciated by clinical or dermatoscopic examination alone. We present optical coherence tomography images of a cherry hemangioma to demonstrate the precision and resolution of this imaging modality. Optical coherence tomography provides valuable information that has the potential to predict response to laser therapy without unnecessary attempts. Future prospective studies will determine its value for this purpose.
J Drugs Dermatol. 2016;15(6):713-714.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 713-714 |
| Number of pages | 2 |
| Journal | Journal of drugs in dermatology : JDD |
| Volume | 15 |
| Issue number | 6 |
| State | Published - Jun 1 2016 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
- Dermatology
Cite this
Utilization of Optical Coherence Tomography in the Evaluation of Cherry Hemangiomas. / Aldahan, Adam S.; Mlacker, Stephanie; Shah, Vidhi V.; Chen, Lucy L.; Nouri, Keyvan; Grichnik, James M.
In: Journal of drugs in dermatology : JDD, Vol. 15, No. 6, 01.06.2016, p. 713-714.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Utilization of Optical Coherence Tomography in the Evaluation of Cherry Hemangiomas
AU - Aldahan, Adam S.
AU - Mlacker, Stephanie
AU - Shah, Vidhi V.
AU - Chen, Lucy L.
AU - Nouri, Keyvan
AU - Grichnik, James M
PY - 2016/6/1
Y1 - 2016/6/1
N2 - Cherry hemangiomas are common vascular proliferative lesions that can be concerning from a cosmetic perspective. Laser therapy is often used to eradicate cherry hemangiomas, but some lesions require multiple treatments or do not resolve at all. The suboptimal response to laser treatment may be due to limitations in penetration depth by vascular lasers such as the pulsed dye laser. Optical coherence tomography is a low-energy, light-based imaging device that can evaluate the depth and extent of vascular lesions such as cherry hemangiomas by allowing visualization of tissue structure and blood vessel architecture, which cannot be appreciated by clinical or dermatoscopic examination alone. We present optical coherence tomography images of a cherry hemangioma to demonstrate the precision and resolution of this imaging modality. Optical coherence tomography provides valuable information that has the potential to predict response to laser therapy without unnecessary attempts. Future prospective studies will determine its value for this purpose. J Drugs Dermatol. 2016;15(6):713-714.
AB - Cherry hemangiomas are common vascular proliferative lesions that can be concerning from a cosmetic perspective. Laser therapy is often used to eradicate cherry hemangiomas, but some lesions require multiple treatments or do not resolve at all. The suboptimal response to laser treatment may be due to limitations in penetration depth by vascular lasers such as the pulsed dye laser. Optical coherence tomography is a low-energy, light-based imaging device that can evaluate the depth and extent of vascular lesions such as cherry hemangiomas by allowing visualization of tissue structure and blood vessel architecture, which cannot be appreciated by clinical or dermatoscopic examination alone. We present optical coherence tomography images of a cherry hemangioma to demonstrate the precision and resolution of this imaging modality. Optical coherence tomography provides valuable information that has the potential to predict response to laser therapy without unnecessary attempts. Future prospective studies will determine its value for this purpose. J Drugs Dermatol. 2016;15(6):713-714.
UR - http://www.scopus.com/inward/record.url?scp=85021308317&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85021308317&partnerID=8YFLogxK
M3 - Article
C2 - 27272077
AN - SCOPUS:85021308317
VL - 15
SP - 713
EP - 714
JO - Journal of Drugs in Dermatology
JF - Journal of Drugs in Dermatology
SN - 1545-9616
IS - 6
ER -